Actinium Pharmaceuticals Inc (ATNM)
8.74
-0.01
(-0.11%)
USD |
NYAM |
May 03, 15:30
Actinium Pharmaceuticals Total Long Term Debt (Quarterly)
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
Date | Value |
---|---|
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2021
--
Maximum
Mar 2021
--
Average
--
Median
Mar 2021
Total Long Term Debt (Quarterly) Benchmarks
Perspective Therapeutics Inc | 1.725M |
Eli Lilly and Co | 26.21B |
Cellectar Biosciences Inc | -- |
Outlook Therapeutics Inc | -- |
Bristol-Myers Squibb Co | 55.68B |